Targeting DNA methylation in cancer

Area of Science:

• Epigenetics
• Cancer Biology
• Molecular Oncology

Background:

• DNA methylation patterns are significantly altered in cancer cells compared to normal cells.
• Aberrant methylation, including regional hypermethylation and global hypomethylation, impacts gene expression critical for cancer progression.
• The DNA methylation machinery involves DNA methyltransferases, regulatory proteins, chromatin modifiers, and demethylases.

Purpose of the Study:

• To review the critical roles of DNA methyltransferases and demethylases in tumorigenesis.
• To explore the pharmacological and therapeutic implications of targeting the DNA methylation machinery in cancer treatment.

Main Methods:

• Literature review of existing studies on DNA methylation in cancer.
• Analysis of data on the function of DNA methylation machinery components.
• Examination of in vitro, in vivo, and clinical trial data regarding pharmacological interventions.

Main Results:

• Cancer cells display distinct DNA methylation profiles, including silencing of tumor suppressor genes and global hypomethylation.
• The DNA methylation machinery is a complex network of enzymes and proteins.
• Pharmacological targeting of DNA methylation machinery components shows promise in inhibiting cancer growth.

Conclusions:

• DNA methylation plays a crucial role in cancer development and progression.
• Targeting DNA methylation machinery offers a potential therapeutic strategy for cancer treatment.
• Further research into the specific functions of DNA methylation machinery is essential for designing effective anticancer agents.